Region: Global
Category: In Vitro Diagnostics

Global In Vitro Diagnostics

(3,924 reports matching your criteria)
  • Prenatal Diagnostics

    ... CAGR of 12.8% over the analysis period 2024-2030. Non-Invasive, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$10.6 Billion by the end of the analysis period. ... Read More

  • Electrophoresis Equipment and Supplies

    ... 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Gel Electrophoresis Systems, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$1.2 Billion by ... Read More

  • Forensic Technologies and Services

    ... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the end ... Read More

  • ADME-Toxicology Testing

    ... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the analysis ... Read More

  • Metabolic Testing Solutions

    ... at a CAGR of 6.8% over the analysis period 2024-2030. CPET Systems, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$324.1 Million by the end of ... Read More

  • Commercial Biotechnology Separation Systems

    ... 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Conventional, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$19.0 Billion by the end ... Read More

  • Veterinary Rapid Testing

    ... at a CAGR of 8.3% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.1 Billion by the end of the ... Read More

  • Rabies Diagnostics

    ... CAGR of 5.4% over the analysis period 2024-2030. Fluorescent Antibody Tests (FAT), one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$910.1 Million by the end of ... Read More

  • Blood Culture Tests

    ... at a CAGR of 5.9% over the analysis period 2024-2030. Conventional Blood Culture Tests, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.3 Billion by the ... Read More

  • Genetic Testing

    ... CAGR of 9.9% over the analysis period 2024-2030. Cancer, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$13.6 Billion by the end of the analysis period. ... Read More

  • Titrators (Automatic and Manual)

    ... 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Coulometric, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$334.3 Million by the end ... Read More

  • Clinical Diagnostics Automation

    ... at a CAGR of 6.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 10.6% CAGR The Clinical Diagnostics Automation market in the U.S. ... Read More

  • Tissue Diagnostics

    ... CAGR of 6.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$8.4 Billion by the end of the analysis period. ... Read More

  • Veterinary Hematology Analyzers

    ... at a CAGR of 5.3% over the analysis period 2024-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end ... Read More

  • Blood Screening

    ... CAGR of 5.5% over the analysis period 2024-2030. Blood Screening Reagents & Kits, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 Billion by the end ... Read More

  • In-Vitro Colorectal Cancer Screening Tests

    ... Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach ... Read More

  • Creatinine Assay Kits

    ... at a CAGR of 2.2% over the analysis period 2024-2030. Jaffe`s Kinetic Test Kits, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$102.1 Million by the ... Read More

  • Dengue Testing

    ... CAGR of 4.8% over the analysis period 2024-2030. ELISA-Based Tests, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$383.2 Million by the end of the analysis ... Read More

  • Human Reproductive Technologies

    ... at a CAGR of 2.2% over the analysis period 2024-2030. Contraceptive Drugs & Devices, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$22.0 Billion by the ... Read More

  • Modular Laboratory Automation

    ... at a CAGR of 6.5% over the analysis period 2024-2030. Automated Liquid Handlers, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.4 Billion by the end ... Read More

  • Hemoglobin A1c (HbA1c) Testing Global Market Report 2025

    ... (hba1c) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More

  • Drug Abuse Testing

    ... at a CAGR of 5.3% over the analysis period 2024-2030. Laboratory Services, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$52.0 Billion by the end of ... Read More

  • Histology and Cytology

    ... at a CAGR of 14.4% over the analysis period 2024-2030. Cytology, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$50.6 Billion by the end of the ... Read More

  • In-Vitro Diagnostics (IVD) Packaging

    ... 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Bottles, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$4.0 Billion by the end ... Read More

  • Antithrombin

    ... 5.3% over the analysis period 2024-2030. Therapeutics, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$847.5 Million by the end of the analysis period. Growth in ... Read More

Cookie Settings